Avid Bioservices Inc (CDMO): Immuno-Oncology Strategies with Combinat...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	86
Posts	12714
Boards Moderated	0
Alias Born	10/12/2010

biopharm

Re: None

Monday, 10/12/2015 8:20:55 PM

Monday, October 12, 2015 8:20:55 PM

Immuno-Oncology Strategies with Combination Therapies
October 15, 2015, 2.30 pm EST

Presenter

Jedd Wolchok
Chief, Melanoma & Immunotherapeutics Service
Associate Director
Ludwig Center for Cancer Immunotherapy
Memorial Sloan-Kettering Cancer Center
View Presenter Biography

Padmanee Sharma
Professor
Department of Genitourinary Medical Oncology
The University of Texas
MD Anderson Cancer Center
View Presenter Biography

K. Dane Wittrup
Principal Investigator
C.P. Dubbs Professor of Chemical Engineering
and Biological Engineering
Associate Director, Koch Institute
for Integrative Cancer Research
View Presenter Biography

Peter Johnson
Professor of Medical Oncology
University of Southampton
View Presenter Biography

Moderator:
Angela Messmer-Blust
Scientific Editor
Conferences and Special Programs

http://view6.workcast.net/register?pak=7525207338728221&referrer=CPtwitter

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!